TABLE 3.
Serological characteristics of initial and passaged C. neoformans strains
| Isolate | IF patterna | Endpoint (μg/ml) | ||||||
|---|---|---|---|---|---|---|---|---|
| MAb 12A1 | MAb 13F1 | IF | Agglutination | |||||
| PBS | 2H1 | PBS | 2H1 | PBS | 2H1 | PBS | 2H1 | |
| 62066 | ||||||||
| P0 | A | A | A | A | 0.1 | 0.1 | 6.25 | 6.25 | 
| P1 | A | A | A | A | 0.1 | <0.01 | 12.5 | 12.5 | 
| P2 | A | A | A | A | 0.1 | 0.1 | 12.5 | 12.5 | 
| P3 | NDb | A | ND | A | ND | 0.1 | ND | 0.1 | 
| 24067 | ||||||||
| P0 | A | A | P | P | <0.01 | <0.01 | 1 | 1 | 
| P1 | A | A | P | P | <0.01 | <0.01 | 0.5 | 1.9 | 
| P2 | A | A | P | P | <0.01 | <0.01 | 1.9 | 1.9 | 
| P3 | A | A | P | P | <0.01 | <0.01 | 1.9 | 1 | 
| P4 | A | A | P | P | <0.01 | <0.01 | 1.9 | 1 | 
| P5 | A | A | P | P | <0.01 | <0.01 | 1 | 1 | 
| C3D | ||||||||
| P0 | A | A | A | A | <0.01 | <0.01 | 0.5 | 0.5 | 
| P1 | A | A | A | A | 0.1 | <0.01 | 0.25 | 0.25 | 
| P2 | A | ND | A | ND | <0.01 | ND | 0.5 | ND | 
| 62066c | ||||||||
| P0 | A | A | A | A | 0.1 | 0.1 | 6.25 | 6.25 | 
| P1 | A | A | A | A | 1 | 1 | 3.9 | 7.8 | 
| C3Dc | ||||||||
| P0 | A | A | A | A | <0.01 | <0.01 | 0.5 | 0.5 | 
| P1 | A | A | A | A | 1 | 0.1 | 0.5 | 1.9 | 
A, annular; P, punctate. Results are for isolated passaged in mice given PBS or 2H1, as indicated.
ND, not done.
Passaged in mice by the organ homogenate method.